Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2000;86:463-469

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Methods
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lang, D.
Right arrow Articles by Lewis, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lang, D.
Right arrow Articles by Lewis, M. J.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Animal models of human disease
Right arrow Hypertension - basic studies
Right arrow Hypertrophy
Right arrow Coronary circulation
Right arrow Oxidant stress
Right arrow Endothelium/vascular type/nitric oxide
(Circulation Research. 2000;86:463.)
© 2000 American Heart Association, Inc.


Cellular Biology

Coronary Microvascular Endothelial Cell Redox State in Left Ventricular Hypertrophy

The Role of Angiotensin II

Derek Lang, Salah I. Mosfer, Alison Shakesby, Francis Donaldson, Malcolm J. Lewis

From the Cardiovascular Sciences Research Group, Sir Geraint Evans Wales Heart Research Institute, Department of Pharmacology, Therapeutics, and Toxicology, University of Wales College of Medicine, Cardiff, Wales.

Correspondence to D. Lang, Department of Pharmacology, Therapeutics, and Toxicology, University of Wales College of Medicine, Heath Park, Cardiff, CF14 4XN UK. E-mail langd{at}cf.ac.uk

Abstract—Left ventricular hypertrophy (LVH) is associated with elevated plasma angiotensin II (Ang II) levels and endothelial dysfunction. The relationship between Ang II and endothelial dysfunction remains unknown, however, but it may involve an alteration in endothelial cell redox state. We therefore investigated the effect of Ang II on NADH/NADPH oxidase–mediated superoxide anion (O2-) production by cultured guinea pig coronary microvascular endothelial cells (CMVEs) and CMVEs freshly isolated from a guinea pig, pressure-overload model of LVH. Lucigenin chemiluminescence was used to measure O2- production in the particulate fraction of CMVE lysates. In cultured cells, incubation with Ang II (0.1 nmol/L to 1 µmol/L for 18 hours) resulted in significant (P<0.01) increases in both NADH- and NADPH-dependent O2- production, with a peak effect at 1 nmol/L. The latter was significantly (P<0.01) inhibited by the AT1 receptor antagonist losartan (1 µmol/L for 18 hours). In contrast, the O2- response to Ang II (0.1 nmol/L to 1 µmol/L for 18 hours) was largely unaffected by concomitant exposure to the AT2 antagonist PD 123319 (1 µmol/L). In freshly isolated CMVEs from nonoperated animals, NADH- and NADPH-dependent O2- production was not different from that in sham-operated animals but was significantly (P<0.05) elevated in the aortic-banded animals. Plasma Ang II levels were significantly (P<0.001) elevated in the aortic-banded (1.25±0.12 µg/L, n=12) compared with sham-operated animals (0.63±0.06 µg/L, n=12). These data suggest that the endothelial dysfunction associated with LVH may be due, at least in part, to the Ang II–induced upregulation of NADH/NADPH oxidase-dependent O2- production.


Key Words: NADH/NADPH oxidase • coronary microvascular endothelium • angiotensin II • left ventricular hypertrophy • superoxide anion




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
G.-X. Zhang, X.-M. Lu, S. Kimura, and A. Nishiyama
Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation
Cardiovasc Res, November 1, 2007; 76(2): 204 - 212.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. A. Polikandriotis, H. L. Rupnow, S. C. Elms, R. E. Clempus, D. J. Campbell, R. L. Sutliff, L. A. S. Brown, D. M. Guidot, and C. M. Hart
Chronic Ethanol Ingestion Increases Superoxide Production and NADPH Oxidase Expression in the Lung
Am. J. Respir. Cell Mol. Biol., March 1, 2006; 34(3): 314 - 319.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Z. Ungvari, A. Csiszar, P. M. Kaminski, M. S. Wolin, and A. Koller
Chronic High Pressure-Induced Arterial Oxidative Stress: Involvement of Protein Kinase C-Dependent NAD(P)H Oxidase and Local Renin-Angiotensin System
Am. J. Pathol., July 1, 2004; 165(1): 219 - 226.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Kinugawa, H. Post, P. M. Kaminski, X. Zhang, X. Xu, H. Huang, F. A. Recchia, M. Ochoa, M. S. Wolin, G. Kaley, et al.
Coronary Microvascular Endothelial Stunning After Acute Pressure Overload in the Conscious Dog Is Caused by Oxidant Processes: The Role of Angiotensin II Type 1 Receptor and NAD(P)H Oxidase
Circulation, December 9, 2003; 108(23): 2934 - 2940.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Higashi, H. Shimokawa, T. Hattori, J. Hiroki, Y. Mukai, K. Morikawa, T. Ichiki, S. Takahashi, and A. Takeshita
Long-Term Inhibition of Rho-Kinase Suppresses Angiotensin II-Induced Cardiovascular Hypertrophy in Rats In Vivo: Effect on Endothelial NAD(P)H Oxidase System
Circ. Res., October 17, 2003; 93(8): 767 - 775.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Mori and A. W. Cowley Jr
Angiotensin II-NAD(P)H Oxidase-Stimulated Superoxide Modifies Tubulovascular Nitric Oxide Cross-Talk in Renal Outer Medulla
Hypertension, October 1, 2003; 42(4): 588 - 593.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-M. Li and A. M. Shah
Mechanism of Endothelial Cell NADPH Oxidase Activation by Angiotensin II. ROLE OF THE p47phox SUBUNIT
J. Biol. Chem., March 28, 2003; 278(14): 12094 - 12100.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. L. Brutsaert
Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity
Physiol Rev, January 1, 2003; 83(1): 59 - 115.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. S. Gragasin, Y. Xu, I. A. Arenas, N. Kainth, and S. T. Davidge
Estrogen Reduces Angiotensin II-Induced Nitric Oxide Synthase and NAD(P)H Oxidase Expression in Endothelial Cells
Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 38 - 44.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Cai, Z. Li, S. Dikalov, S. M. Holland, J. Hwang, H. Jo, S. C. Dudley Jr., and D. G. Harrison
NAD(P)H Oxidase-derived Hydrogen Peroxide Mediates Endothelial Nitric Oxide Production in Response to Angiotensin II
J. Biol. Chem., December 6, 2002; 277(50): 48311 - 48317.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
U. Rueckschloss, M. T. Quinn, J. Holtz, and H. Morawietz
Dose-Dependent Regulation of NAD(P)H Oxidase Expression by Angiotensin II in Human Endothelial Cells: Protective Effect of Angiotensin II Type 1 Receptor Blockade in Patients With Coronary Artery Disease
Arterioscler Thromb Vasc Biol, November 1, 2002; 22(11): 1845 - 1851.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J.-M. Li, N. P. Gall, D. J. Grieve, M. Chen, and A. M. Shah
Activation of NADPH Oxidase During Progression of Cardiac Hypertrophy to Failure
Hypertension, October 1, 2002; 40(4): 477 - 484.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Hu, Z.-X. Yu, V. J. Ferrans, K. Takeda, K. Irani, and R. C. Ziegelstein
Critical Role of NADPH Oxidase-derived Reactive Oxygen Species in Generating Ca2+ Oscillations in Human Aortic Endothelial Cells Stimulated by Histamine
J. Biol. Chem., August 30, 2002; 277(36): 32546 - 32551.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
L Van Heerebeek, C Meischl, W Stooker, C J L M Meijer, H W M Niessen, and D Roos
NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system?
J. Clin. Pathol., August 1, 2002; 55(8): 561 - 568.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D Lang
Cardiac hypertrophy and oxidative stress: a leap of faith or stark reality?
Heart, April 1, 2002; 87(4): 316 - 317.
[Full Text] [PDF]


Home page
CirculationHome page
P. A. MacCarthy, D. J. Grieve, J.-M. Li, C. Dunster, F. J. Kelly, and A. M. Shah
Impaired Endothelial Regulation of Ventricular Relaxation in Cardiac Hypertrophy: Role of Reactive Oxygen Species and NADPH Oxidase
Circulation, December 11, 2001; 104(24): 2967 - 2974.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Bell, S. I. Mosfer, D. Lang, F. Donaldson, and M. J. Lewis
Vitamin C and quinapril abrogate LVH and endothelial dysfunction in aortic-banded guinea pigs
Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1704 - H1710.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A.H. Henderson
'It all used to be so simple in the old days'. A personal view
Eur. Heart J., April 2, 2001; 22(8): 648 - 653.
[PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. K. Griendling, D. Sorescu, B. Lassegue, and M. Ushio-Fukai
Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology
Arterioscler Thromb Vasc Biol, October 1, 2000; 20(10): 2175 - 2183.
[Abstract] [Full Text] [PDF]